期刊文献+

阿司匹林抵抗的机制 被引量:2

Mechanisms of aspirin resistance
原文传递
导出
摘要 近年来,阿司匹林抵抗现象越来越引起重视。研究人员已从多个方面对这种重要现象的机制进行了探索,包括患者依从性、实验室检测方法、阿司匹林剂量、遗传学、药物相互作用等;并提出了相应的管理方法,如提高患者依从性、避免药物相互作用、调整药物剂量、加用其他有潜在应用价值的抗血小板药等。文章对阿司匹林抵抗机制的研究进展进行了综述。 In recent years, more and more attention has been given to aspirin resistance. Researchers have explored the mechanisms of this important phenomenon from several aspects, including patient compliance, laboratory tests, aspirin dose, genetics, and drug interactions. Many appropriate management methods of aspirin resistance have been proposed, such as improving patient compliance, avoiding drug interactions, adjusting dose, and adding other antiplatelet drugs with potential application value. This article reviews the advances in research on the mechanisms of aspirin resistance.
出处 《国际脑血管病杂志》 北大核心 2011年第11期836-840,共5页 International Journal of Cerebrovascular Diseases
关键词 阿司匹林 血小板聚集抑制药 抗药性 卒中 Aspirin Platelet aggregation inhibitors Drug resistance Stroke
  • 相关文献

参考文献58

  • 1Yousuf O,Bhatt DL.The evolution of antiplatdet therapy in cardiovascular disease.Nat Rev Cardiol,2011,8:547-559.
  • 2Maree AO,Curtin RJ,Dooley M,et al.Platelet response to low-dose enteric-corted aspirin in patients with stable cardiovascular disease.J Am Coll Cardiol,2005,46:1258-1263.
  • 3van t Hof AW,Valgimigli M.Defining the role of platelet glycoprotein receptor inhibitors in STEMI:focus on tirofiban.Drugs,2009,69:85-100.
  • 4Gengo FM,Rainka M,Robson M,et al.Prevalence of platelet nonre-sponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.J Clin Pharmacol,2008,48:335-343.
  • 5Top(c)uoglu MA,Arsava EM,Ay H.Antiplatelet resistance in stroke.Expert Rev Neurother,2011,11:251-263.
  • 6Greer DM.Aspirin and antiplatelet agent resistance:implications for prevention of secondary stroke.CNS Drugs,2010,24:1027-1040.
  • 7Quick AJ.Salicylates and bleeding:the aspirin tolerance test.Am J Med Sci,1966,252:265-269.
  • 8Farré AJ,Tamargo J,Mateos-C6ceres PJ,et al.Old and new molecular mechanisms associated with platelet resistance to antithrombotics.Pharm Res,2010,27:2365-2373.
  • 9Michelson AD.Platelet function testing in cardiovascular diseases.Circulation,2004,110:e489-e493.
  • 10Tantry US,Bliden KP,Gurbel PA.Overestimation of platelet aspirin resistance detection by thrombelastogaph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.J Am Coll Cardiol,2005,46:1705-1709.

同被引文献52

  • 1陈静.阿司匹林抵抗与脑梗死防治[J].黑龙江医学,2013,37(5):369-370. 被引量:6
  • 2Furie KL,Kasner SE,Adams RJ,et al; American Heart Association Stroke Council,Council on Cardiovascular Nursing,Council on Clinical Cardiology,and Interdisciplinary Council on Quality of Care and Outcomes Research.Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack:a guideline for healthcare professionals from the american heart association/american stroke association.Stroke,2011,42:227-276.
  • 3Angiolillo D J,Fernandez-Ortiz A,Bernardo E,et al.Variability in individual responsiveness to clopidogrel:clinical implications,management,and future perspectives.J Am Coll Cardiol,2007,49:1505-1516.
  • 4Bhatt DL.Aspirin resistance:more than just a laboratory curiosity.J Am Coil Cardiol,2004,43:1127-1129.
  • 5Alberts MJ.Platelet function testing for aspirin resistance is reasonable to do:yes! Stroke,2010,41:2400-2401.
  • 6Bliden KP,DiChiara J,Tantry US,et al.Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention:is the current antiplatelet therapy adequate? J Am Coll Cardiol,2007,49:657-666.
  • 7van Werkum JW,van der Stelt CA,Seesing TH,et al.A head-tohead comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.J Thromb Haemost,2006,4:2516-2518.
  • 8Rowe AS,Greene CL,Snider CC,et al.Thromboelastographic changes in patients experiencing an acute ischemic stroke and receiving alteplase.J Stroke Cerebrovasc Dis,2014,23:1307-1311.
  • 9Kreutz RP,Owens J,Breall JA,et al.C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.Blood Coagul Fibrinolysis,2013,24:321-326.
  • 10Rafil S,Johansson PI,Zacho M,et al.Thrombelastographic haemostatic starus and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial):assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients:study protocol for a randomized controlled trial.Trials,2012,13:48.

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部